TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 69.50
-1.30 (-1.84%)
At close: Jul 9, 2026
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 19.34 billion as of July 9, 2026. Its market cap has decreased by -23.52% in one year.
Market Cap
19.34B
Enterprise Value
18.19B
Revenue
601.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
69.50
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 19.34B, an increase of 649.59%. That is a compound annual growth rate of 13.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 18.99B | 13.56% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 26.70B |
| CHO Pharma | 23.22B |
| Sunmax Biotechnology | 21.05B |
| Ever Supreme Bio Technology | 18.62B |
| Lumosa Therapeutics | 16.75B |
| Medigen Vaccine Biologics | 15.62B |
| EirGenix | 15.11B |
| Gongwin Biopharm Holdings | 14.24B |